Back

Characterization of the arrhythmogenic substrate with multimodality imaging in ischemic patients undergoing VT ablation: relationship between cardiac computed tomography and magnetic resonance

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: The substrate for ventricular arrhythmia - From ECG to non-invasive therapy Ablation of Ventricular Arrhythmias ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Giulio Zucchelli

University Hospital of Pisa, Pisa (Italy)

4 More presentations in this session

Presentation thumbnail
State of the Art - Imaging for substrate identification in ventricular arrhythmia
Professor P. Jais (Neuilly sur Seine, FR)
Slides Video
Presentation thumbnail
Manifestations of myocardial fibrosis in the standard 12-lead electrocardiogram
Mr L. Holmstrom (Oulu, FI)
Abstract Slides Video
Presentation thumbnail
Long-term safety of stereotactic body radiotherapy for ablation of ventricular tachycardia: a multicentric study
Mr J. Cvek (Ostrava, CZ)
Abstract Slides Video
Presentation thumbnail
Non-invasive therapy for ventricular arrhythmia.
Doctor D. Packer (Salt Lake City, US)
Slides Video

Access the full session

Session thumbnail
The substrate for ventricular arrhythmia - From ECG to non-invasive therapy

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?
thumbnail
Congress Presentation
Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?
thumbnail
Congress Presentation
Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources